Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2015, Article ID 980310, 4 pages
http://dx.doi.org/10.1155/2015/980310
Research Article

Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?

1Department of Dermatology, Haseki Training and Research Hospital, 34080 Istanbul, Turkey
2Department of Dermatology, Mugla Sitki Kocman University Training and Research Hospital, 48000 Mugla, Turkey

Received 5 July 2015; Revised 20 October 2015; Accepted 22 October 2015

Academic Editor: Craig G. Burkhart

Copyright © 2015 Seyran Ozbas Gok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. There are several studies investigating the relationship between androgenetic alopecia (AGA) and metabolic syndrome (MS) with conflicting results. Objective. We sought to investigate whether there is a relationship between AGA and MS. Methods. A case-control study including 74 male patients with AGA and 42 male controls was conducted. Age, duration of AGA, AGA onset age, anthropometric measures, body mass index, lipid parameters, fasting blood glucose, blood pressure, and presence of MS were recorded. Results. Of the 74 male AGA patients (age range 20–50 years, mean 32.14), 24 were in stage 2, 26 were in stage 3, 17 were in stage 3V, 1 was in stage 5, and 6 were in stage 7. There was no significant difference in the rate of MS between AGA and control groups . Among the evaluated parameters, only systolic blood pressure in AGA group was significantly higher than control group. Conclusion. In contrast to the most of the previous studies, our study does not support the link between AGA and MS. To exclude confounding factors such as advanced age and therefore metabolic disturbances, further studies are needed with large group of AGA patients including different age groups and varying severity.